Equities
  • Price (USD)29.88
  • Today's Change-0.61 / -2.00%
  • Shares traded1.04m
  • 1 Year change+3.18%
  • Beta0.8005
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

  • Revenue in USD (TTM)5.19bn
  • Net income in USD213.77m
  • Incorporated1996
  • Employees6.02k
  • Location
    Option Care Health Inc3000 Lakeside Dr, Suite 300NBANNOCKBURN 60015United StatesUSA
  • Phone+1 (312) 940-2443
  • Fax+1 (302) 636-5454
  • Websitehttps://optioncarehealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OPCH:NSQ since
announced
Transaction
value
Intramed Plus IncDeal completed13 Jan 202513 Jan 2025Deal completed24.55%--
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Privia Health Group Inc1.80bn15.62m2.50bn1.14k165.483.7791.051.390.12370.123714.275.431.63--4.901,580,039.001.81-3.813.22-6.2710.099.481.11-2.05----0.00--4.7417.17-37.6711.78----
Concentra Group Holdings Parent Inc1.93bn156.04m2.55bn8.76k9.118.3111.211.322.192.1920.752.400.7589--7.93220,752.006.37--7.29--27.98--8.39----3.530.8316--3.38---7.45------
Alignment Healthcare Inc3.00bn-90.63m2.65bn1.68k--24.44--0.8812-0.4729-0.472915.640.5473.93--15.841,787,905.00-11.88-24.01-24.59-39.6311.5712.08-3.03-7.96---2.820.747--48.2528.9913.50--32.23--
Surgery Partners Inc3.17bn-193.40m2.82bn15.00k--1.6219.740.8902-1.53-1.5325.1313.580.425228.255.96211,526.70-0.16220.9726-0.22851.3626.5126.23-0.38142.461.732.500.4975--13.5211.20-1,312.61--4.20--
Amedisys Inc2.37bn89.84m3.19bn19.00k35.962.6621.761.342.702.7071.7936.551.11--6.99124,825.804.005.905.347.8343.3744.003.604.87----0.22930.005.013.73543.53-19.37-1.34--
Sotera Health Co1.11bn24.78m3.35bn3.00k136.578.0917.733.030.08640.08643.881.460.35958.838.04368,929.300.806-0.39770.8588-0.443355.1755.042.24-1.192.192.120.8484--4.887.17-13.21--25.61--
Brightspring Health Services Inc11.57bn37.44m3.58bn37.00k113.432.1115.390.30970.1790.271256.249.632.0122.0611.77312,647.700.61-0.61450.7982-0.760913.4616.650.3033-0.3971.371.630.6011--27.6520.0188.32--9.58--
Hinge Health Inc431.52m-72.50m3.72bn1.51k------8.61-0.9294-0.92945.535.62------285,020.50--------79.30--7.34--2.26--0.00--33.37--88.97------
Radnet Inc1.87bn-32.35m4.16bn8.55k--4.6320.312.23-0.4421-0.442124.5811.980.5929--8.15218,740.500.1171.200.14971.5922.6122.020.19731.90--1.050.47060.0013.189.65-8.25-28.3220.46--
Option Care Health Inc5.19bn213.77m4.89bn6.02k23.863.6217.580.94361.251.2530.388.251.5813.589.87862,031.906.525.158.216.2720.0121.934.123.861.027.810.45120.0016.1716.69-20.69--4.71--
CorVel Corp895.59m95.17m5.03bn5.08k53.4215.6040.345.621.831.8317.226.271.79--8.90176,470.7019.0216.1631.0926.6623.4422.6010.639.71----0.000.0012.618.6224.8014.972.02--
Chemed Corp2.49bn308.74m6.73bn15.70k22.405.6718.092.7020.5320.53165.4781.091.44175.3710.75158,585.3017.8819.2021.4324.0534.8235.2012.4012.781.70--0.00048.197.374.6310.826.55-1.357.74
Data as of Jul 11 2025. Currency figures normalised to Option Care Health Inc's reporting currency: US Dollar USD

Institutional shareholders

52.64%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 202519.20m11.62%
The Vanguard Group, Inc.as of 31 Mar 202517.94m10.85%
Wellington Management Co. LLPas of 31 Mar 202515.43m9.34%
Durable Capital Partners LPas of 06 Jun 20258.24m4.98%
SSgA Funds Management, Inc.as of 31 Mar 20256.47m3.92%
Geode Capital Management LLCas of 31 Mar 20254.30m2.60%
Fuller & Thaler Asset Management, Inc.as of 31 Mar 20254.20m2.54%
Westfield Capital Management Co. LPas of 31 Mar 20254.14m2.51%
Fidelity Management & Research Co. LLCas of 31 Mar 20253.89m2.35%
Dimensional Fund Advisors LPas of 31 Mar 20253.20m1.94%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.